Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)

Market Cap	4.38T
Revenue (ttm)	492.09B
Net Income (ttm)	103.89B
Shares Out	2.40B
EPS (ttm)	43.31
PE Ratio	42.13
Forward PE	39.85
Dividend	13.50 (0.74%)
Ex-Dividend Date	Jul 12, 2024

Volume	1,700,942
Open	1,819.55
Previous Close	1,826.50
Day's Range	1,805.00 - 1,850.00
52-Week Range	1,068.35 - 1,850.00
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About SUNPHARMA

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and othe...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1983
• Employees: 43,000
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUNPHARMA

Financial Performance

In 2023, SUNPHARMA's revenue was 484.97 billion, an increase of 10.51% compared to the previous year's 438.86 billion. Earnings were 95.76 billion, an increase of 13.01%.